BRPI1000802B8 - process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles - Google Patents

process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles

Info

Publication number
BRPI1000802B8
BRPI1000802B8 BRPI1000802A BRPI1000802A BRPI1000802B8 BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8 BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8
Authority
BR
Brazil
Prior art keywords
matrix microparticles
microparticles
aerial parts
copaiferous
langsdorffii
Prior art date
Application number
BRPI1000802A
Other languages
Portuguese (pt)
Inventor
Aparecida Berretta E Silva Andresa
Rodrigues Flores Brunharoto Aurita
Kenupp Bastos Jairo
Original Assignee
Apis Flora Indl Coml Ltda
Rodrigues Flores Brunharoto Aurita
Univ Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apis Flora Indl Coml Ltda, Rodrigues Flores Brunharoto Aurita, Univ Sao Paulo filed Critical Apis Flora Indl Coml Ltda
Priority to BRPI1000802A priority Critical patent/BRPI1000802B8/en
Priority to PCT/BR2011/000090 priority patent/WO2011120118A1/en
Publication of BRPI1000802A2 publication Critical patent/BRPI1000802A2/en
Publication of BRPI1000802B1 publication Critical patent/BRPI1000802B1/en
Publication of BRPI1000802B8 publication Critical patent/BRPI1000802B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

processo de obtenção de micropartículas matriciais de copaífera langsdoffíi (partes aéreas) e isolamento dos princípios ativos; micropartículas e compostos assim obtidos, com atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, suas formulações, produtos e usos. refere-se o presente invento a um processo de obtenção de micropartículas matriciais de copaifera iangsdorffii (partes aéreas) e do isolamento dos compostos ativos e/ou marcadores das partes aéreas da referida planta, bem como as atividades biológicas encontradas para tais micropartículas matriciais e dos compostos isolados, quais sejam: atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, bem como a utilização destes nos tratamentos de litíase renal (cálculo renal), artrites, tártaros, dores musculares e espasmódicas em geral (cólicas abdominais, renais, etc.). refere-se também as demais doenças relacionadas às atividades previamente citadas, além das formulações que podem ser originadas com as micropartículas matriciais de copaifera iangsdorffii; e/ou seus compostos isolados, como medicamentos, produtos de higiene pessoal, cosméticos, alimentos, produtos veterinários e odontológicos, etc.process for obtaining matrix microparticles of langsdoffii copaifera (aerial parts) and isolation of the active principles; microparticles and compounds thus obtained, with antilithiasic (kidney calculus), analgesic, antispasmodic, anti-inflammatory, diuretic and antiseptic activity, their formulations, products and uses. the present invention relates to a process for obtaining copaifera iangsdorffii matrix microparticles (aerial parts) and the isolation of active compounds and/or markers from the aerial parts of said plant, as well as the biological activities found for such matrix microparticles and the isolated compounds, namely: antilithiasis (kidney calculus), analgesic, antispasmodic, anti-inflammatory, diuretic and antiseptic activity, as well as their use in the treatment of renal lithiasis (kidney calculus), arthritis, tartars, muscle pain and spasmodic in general (abdominal, kidney cramps, etc.). it also refers to other diseases related to the activities previously mentioned, in addition to the formulations that can be originated with the copaifera iangsdorffii matrix microparticles; and/or its isolated compounds, such as medicines, personal care products, cosmetics, foods, veterinary and dental products, etc.

BRPI1000802A 2010-03-30 2010-03-30 process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles BRPI1000802B8 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI1000802A BRPI1000802B8 (en) 2010-03-30 2010-03-30 process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles
PCT/BR2011/000090 WO2011120118A1 (en) 2010-03-30 2011-03-29 Method for preparing matrix micro-particles of copaífera langsdorffii (aerial parts) and for isolating the active principles therein; thus prepared analgesic, anti-spasmodic, anti-inflammatory, diuretic and antiseptic micro-particles and compounds with anti-lithiasis activity (renal calculi), formulations, products and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1000802A BRPI1000802B8 (en) 2010-03-30 2010-03-30 process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles

Publications (3)

Publication Number Publication Date
BRPI1000802A2 BRPI1000802A2 (en) 2011-11-22
BRPI1000802B1 BRPI1000802B1 (en) 2020-12-29
BRPI1000802B8 true BRPI1000802B8 (en) 2021-09-08

Family

ID=44711247

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1000802A BRPI1000802B8 (en) 2010-03-30 2010-03-30 process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles

Country Status (2)

Country Link
BR (1) BRPI1000802B8 (en)
WO (1) WO2011120118A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
BRPI0401631A (en) * 2004-04-22 2005-12-06 Aurita Rodrigues Fl Brunharoto Process for obtaining and using extracts, fractions and substances isolated from copafera species in the treatment of urolithiasis in humans and animals

Also Published As

Publication number Publication date
BRPI1000802B1 (en) 2020-12-29
BRPI1000802A2 (en) 2011-11-22
WO2011120118A1 (en) 2011-10-06

Similar Documents

Publication Publication Date Title
BR112014009851A2 (en) nmda receptor modulators and uses thereof
BR112012016575A2 (en) skin care composition / dermatological, plant-produced heterologous growth factor, and method for making a topical product
BR112014031730A2 (en) chemical entities, pharmaceutical compositions, pharmaceutically acceptable compounds or salts thereof, uses of chemical entities or compositions and methods for treating diseases, disorders or medical conditions mediated by pde1 enzymatic activity and for modulating pde1 enzyme activity
EA201101424A1 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF THEIR APPLICATION
MX2010004613A (en) Topical composition.
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
EA201391119A1 (en) DELIVERY SYSTEMS OF NANOPARTICLES, THEIR RECEIVING AND APPLICATION
BRPI0720500A8 (en) TRANSDERMAL LIQUID PREPARATION
AR054249A1 (en) TREATMENT OF SKIN CONNECTIVE TISSUE DISEASES
BR112015005339A8 (en) use of miracle fruit seed oil as an active ingredient
EA201270615A1 (en) ANTIGROUSE PREPARATION CONTAINING FUNGAL ORGANISM
Rahimi et al. Molecular docking and binding study of harpagoside and harpagide as novel anti-inflammatory and anti-analgesic compound from Harpagophytum procumbens based on their interactions with COX-2 enzyme
BR112014005398A2 (en) peptide that inhibits the use of matrix metalloproteinases and its use
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
BR112015012057A2 (en) fungicidal binary mixtures
EA201390345A1 (en) THERAPEUTIC HOSE MEDICINE
BRPI1000802B8 (en) process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles
MX2016007973A (en) Topical composition comprising natural ingredients for bruising or hematoma healing on skin and use thereof.
ES2387109B1 (en) PHARMACEUTICAL SPRAYING
BR112012025537A2 (en) therapeutic use of ß2m protein
CN101658538A (en) Medicament for treating scalds
GB2436524A (en) Topical composition comprising an extract of the butterbur plant
Borthakur Treatment of diseases in the Atharvaveda: an observation
BR112014032850A2 (en) combinations of active ingredients, cosmetic or dermatological preparations, and use of combinations of active ingredients
Johnston Muscle and joint pain: topical anti-inflammatories and analgesics: therapeutic

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2608 DE 29/12/2020 QUANTO AO ENDERECO.